Abstract
With this issue of The Lancet Infectious Diseases, I thank the 985 individuals who submitted a peer review report for the journal in 2021 (944 subject reviewers and 41 statistical). During a second year in which the infectious diseases community has been focused on responding to the COVID-19 pandemic, I am grateful to all those people who have found time for peer review of their colleagues’ papers. Peer review remains an essential—if imperfect—part of the process of verifying the scientific record. Thank you to The Lancet Infectious Diseases clinical and statistical peer reviewers in 2021Peter Aaby Full-Text PDF
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.